Cytovance Biologics Email Format
Biotechnology ResearchOklahoma, United States51-200 Employees
Cytovance Biologics is a contract development and manufacturing organization (CDMO) in the biotechnology sector, offering end-to-end biomanufacturing capabilities based on microbial and mammalian expression systems. Its services span from early-stage development, including cell line development and strain selection, to cGMP manufacturing for clinical and commercial production. The company is based in Oklahoma City, Oklahoma, and employs 51 to 200 people. It has formed strategic partnerships to expand capabilities, including a 2025 integration with PolyPeptide Laboratories for peptide development and manufacturing, a 2024 collaboration with ExcellGene SA for mammalian cell line development, and a 2023 partnership with Vectron Biosolutions for customized E. coli strain development. Its product focus encompasses a range of biologics such as biosimilars, cytokines, enzymes and hormones, fusion proteins, bispecifics and monoclonal antibodies, recombinant proteins, vaccines, and related modalities.
1-888-653-2347 
support@leadiq.com 
